STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has signed an agreement to acquire Recip AB – a Nordic pharmaceutical company with strong growth. According to the agreement Meda takes over the existing Recip AB sales and organisation. Meda also obtains product rights, trademarks and right to the Recip name. Recipharm, a production company, will continue as a contract manufacturer for Meda and isn’t part of the deal. The acquisition is expected to contribute sales of about SEK 850 million into Meda’s operation during 2008 and strengthens Meda in several significant respects:
